Ghost Tree Capital’s TG Therapeutics TGTX Stock Holding History

Ghost Tree Capital’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$7.25M	Sell	310,000 -190,000	-38%	-$4.15M	2.19%	18
2024 Q2	$8.89M	Sell	500,000 -325,000	-39%	-$5.19M	2.79%	12
2024 Q1	$12.5M	Buy	825,000 +575,000	+230%	+$9.16M	3.47%	7
2023 Q4	$4.27M	Sell	250,000 -750,000	-75%	-$8.72M	1.4%	23
2023 Q3	$8.36M	Buy	1,000,000 +175,000	+21%	+$2.44M	2.75%	8
2023 Q2	$20.5M	Sell	825,000 -275,000	-25%	-$7.1M	6.77%	2
2023 Q1	$16.5M	Buy	+1,100,000	New	+$16.7M	4.89%	4
2021 Q3	–	Sell	-180,000	Closed	-$6.98M	–	67
2021 Q2	$6.98M	Sell	180,000 -20,000	-10%	-$785K	1.92%	16
2021 Q1	$9.64M	Sell	200,000 -50,000	-20%	-$2.4M	2.27%	15
2020 Q4	$13M	Buy	250,000 +50,000	+25%	+$1.69M	2.9%	14
2020 Q3	$5.35M	Sell	200,000 -400,000	-67%	-$9.2M	1.55%	22
2020 Q2	$11.7M	Buy	600,000 +400,000	+200%	+$6.44M	3.08%	14
2020 Q1	$1.97M	Buy	200,000 +137,000	+217%	+$1.73M	0.52%	35
2019 Q4	$699K	Buy	+63,000	New	+$479K	0.13%	50
2018 Q4	–	Sell	-45,500	Closed	-$255K	–	56
2018 Q3	$255K	Sell	45,500 -6,500	-13%	-$74.3K	0.05%	55
2018 Q2	$684K	Sell	52,000 -248,000	-83%	-$3.41M	0.2%	42
2018 Q1	$4.26M	Buy	+300,000	New	+$3.83M	0.86%	37

Other funds holding TGTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ghost Tree Capital's TGTX Position: Q3 2024 in Review

Ghost Tree Capital reduced its TG Therapeutics (TGTX) stake by 38% in Q3 2024, selling an estimated $4.15M and leaving 310,000 shares worth $7.25M. The position accounts for 2.19% of the portfolio, ranked #18.

Ghost Tree Capital first reported a position in TGTX in Q1 2018 and has held it in 17 quarters since. The position peaked at $20.5M in Q2 2023. 308 funds tracked by Wall St. Rank hold TGTX as of Q3 2024.

Ghost Tree Capital held 310,000 shares of TG Therapeutics worth $7.25M as of Q3 2024.
Ghost Tree Capital sold 190,000 TG Therapeutics shares in Q3 2024, an estimated $4.15M.
TG Therapeutics made up 2.19% of Ghost Tree Capital's portfolio in Q3 2024, its #18 holding.
Ghost Tree Capital first reported a position in TG Therapeutics in Q1 2018 and has held it in 17 quarters since.
Ghost Tree Capital's TG Therapeutics position peaked at $20.5M in Q2 2023.
308 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.